Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trial

This could change the lives of millions, including myself. A world free from COVID and long COVID seems like a dream.

“While the current, needle-based COVID-19 vaccines have prevented a tremendous amount of death and hospitalization, they haven't really changed a lot of people's experience with getting recurrent infections. So, we're looking to change that by providing robust protection directly at the site of infection."

Fiona Smaill, Professor, Department of Pathology & Molecular Medicine, McMaster University